| Literature DB >> 34940688 |
Hongxu Li1,2, Xinyi Liu1, Xiaofan Li1, Zhangli Hu1,2, Liyan Wang1.
Abstract
Five undescribed harziane-type diterpene derivatives, namely harzianol K (1), harzianol L (4), harzianol M (5), harzianol N (6), harzianol O (7), along with two known compounds, hazianol J (2) and harzianol A (3) were isolated from the deep-sea sediment-derived fungus Trichoderma sp. SCSIOW21. The relative configurations were determined by meticulous spectroscopic methods including 1D, 2D NMR spectroscopy, and HR-ESI-MS. The absolute configurations were established by the ECD curve calculations and the X-ray crystallographic analysis. These compounds (1, and 4-7) contributed to increasing the diversity of the caged harziane type diterpenes with highly congested skeleton characteristics. Harzianol J (2) exhibited a weak anti-inflammatory effect with 81.8% NO inhibition at 100 µM.Entities:
Keywords: NO inhibition; Trichoderma; harziane diterpenes
Mesh:
Substances:
Year: 2021 PMID: 34940688 PMCID: PMC8705903 DOI: 10.3390/md19120689
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Compounds 1–7 and harziandione.
1H NMR spectroscopy (600 MHz) a of compounds 1, 4–7.
| 1 | 4 | 5 | 6 | 7 | |
|---|---|---|---|---|---|
| No. | δH ( | δH ( | δH ( | δH ( | δH ( |
| 1 | |||||
| 2 | 2.06, d (8.0) | 2.26, dd (11.0, 8.0) | |||
| 2-OH | 4.17, s | 4.14, s | |||
| 3α | 1.81, m b | 1.77, m | 1.78, m | 1.80, m | |
| 3β | 1.32, dd (12.0, 7.0) | 1.30, dd (12.0, 7.0) | 1.23, m | 1.31, m b | |
| 4α | 2.92, dd (17.0, 11.0) | 1.80, m | 1.85, m | 1.89, m | 1.85, m |
| 4β | 1.84, d (17.0) | 1.64, d (12.0) | 1.60, m | 1.48, dd (14.0, 6.0) | 1.34, m |
| 5 | 3.38, m | 2.13, t (8.0) | 2.71, t (8.0) | 2.75, t (8.0) | 2.32, m b |
| 6 | |||||
| 7α | 2.16, dd (15.0, 5.0) | 1.76, m b | 2.11, dd (15.0, 5.0) | 2.14, dd (15.0, 5.0) | 2.35, m b |
| 7β | 1.36, dd (15.0, 2.0) | 1.28, m | 1.36, dd (15.0, 2.0) | 1.30, dd (15.0, 2.0) | 1.90, ddd (13.0, 7.0, 2.0) |
| 8α | 4.24, d (5.0, 2.0) | 2.52, m | 4.21, dd (5.0, 2.0) | 4.22, dd (5.0, 2.0) | 1.98, dd (13.0, 7.0) |
| 8β | 1.88, ddd (16.0, 6.0, 2.0) | 1.29, m b | |||
| 8-OH | 5.31, brs | 5.45, brs | |||
| 9 | |||||
| 10 | |||||
| 11 | |||||
| 12α | 2.77, d (16.0) | 2.60, d (16.0) | 2.65, d (16.0) | 2.71, d (16.0) | 2.98, d (16.0) |
| 12β | 2.33, d (16.0) | 2.26, d (16.0) | 2.29, d (16.0) | 2.33, d (16.0) | 2.34, d (16.0) |
| 13 | |||||
| 14 | 2.57, dd (11.0, 9.0) | 2.21, dd (12.0, 9.0) | 2.33, dd (12.0, 9.0) | 1.56, m | 2.07, d (6.0) |
| 15α | 1.98, m | 1.58, dd (13.0.0, 9.0) | 1.65, m | 1.84, m | 3.65, d (6.0) |
| 15β | 1.49, dd (14.0, 9.0) | 1.69, dd (13.0,12.0) | 1.57, m | 1.35, m | |
| 16 | 0.93, s | 0.81, s | 0.82, s | 0.80, s | 0.84, s |
| 17 | 0.91, s | 0.66, s | 0.70, s | 0.84, s | 0.89, s |
| 18α | 1.18, d (7.0) | 3.41, m | 3.85, d (10.0) | 3.89, d (10.0) | 0.99, d (7.0) |
| 18β | 3.28, m | 3.23, m | 3.26, m | ||
| 18-OH | 4.39, t (6.0) | ||||
| 19 | 1.53, s | 1.39, s | 1.46, s | 1.51, s | 1.43, s |
| 20 | 2.04, s | 2.01, s | 2.03, s | 2.03, s | 2.02, s |
a Recorded in DMSO-d; b overlapped signals.
13C NMR spectroscopy (150 MHz) a data of Compounds 1, 4–7.
| 1 | 4 | 5 | 6 | 7 | |
|---|---|---|---|---|---|
| No. | δC, Type | δC, Type | δC, Type | δC, Type | δC, Type |
| 1 | 50.5, C | 48.5, C | 49.2, C | 51.1, C | 48.2, C |
| 2 | 58.9, CH | 77.9, C | 77.4, C | 51.8, CH | 75.9, C |
| 3 | 213.6, C | 33.2, CH2 | 33.5, CH2 | 25.5, CH2 | 30.4, CH2 |
| 4 | 43.2, CH2 | 22.6, CH2 | 23.9, CH2 | 22.0, CH2 | 25.2, CH2 |
| 5 | 31.4, CH | 40.1, CH | 41.7, CH | 42.4, CH | 27.5, CH |
| 6 | 51.7, C | 52.7, C | 53.1, C | 45.7, C | 50.7, C |
| 7 | 33.0, CH2 | 30.2, CH2 | 34.3, CH2 | 33.7, CH2 | 29.3, CH2 |
| 8 | 72.4, CH | 29.3, CH2 | 73.5, CH | 73.1, CH | 31.5, CH2 |
| 9 | 144.4, C | 145.5, C | 143.0, C | 143.1, C | 145.8, C |
| 10 | 150.4, C | 149.7, C | 150.0, C | 150.6, C | 149.6, C |
| 11 | 199.6, C | 198.2, C | 200.0, C | 200.1, C | 198.2, C |
| 12 | 58.8, CH2 | 59.2, CH2 | 58.9, CH2 | 58.9, CH2 | 59.1, CH2 |
| 13 | 40.1, C | 40.0, C | 40.7, C | 40.9, C | 40.0, C |
| 14 | 52.2, CH2 | 50.6, CH | 50.5, CH | 42.4, CH | 60.1, CH |
| 15 | 26.1, CH | 35.6, CH2 | 35.7, CH2 | 27.1, CH2 | 73.5, CH |
| 16 | 25.6, CH3 | 19.7, CH3 | 20.1, CH3 | 25.8, CH3 | 20.5, CH3 |
| 17 | 23.4, CH3 | 18.9, CH3 | 19.0, CH3 | 21.9, CH3 | 19.7, CH3 |
| 18 | 22.8, CH3 | 63.9, CH2 | 65.6, CH2 | 65.9, CH2 | 19.9, CH3 |
| 19 | 20.2, CH3 | 21.6, CH3 | 21.0, CH3 | 21.0, CH3 | 22.3, CH3 |
| 20 | 20.1, CH3 | 22.0, CH3 | 20.2, CH3 | 20.2, CH3 | 21.9, CH3 |
a Recorded in DMSO-d
Figure 2Key 2D NMR spectroscopy correlations of compounds 1 and 4–7.
Figure 3Key NOE correlations of compounds 1 and 4–7.
Figure 4Experimental and calculated (for 2S, 5R, 6R, 8S, 13S, 14S) ECD spectra of 1 (a), experimental and calculated (for 2S, 5R, 6R, 13S, 14S) ECD spectra of 4 (b), experimental and calculated (for 2S, 5R, 6R, 8S, 13S, 14S) ECD spectra of 5 (c), experimental and calculated (for 2S, 5R, 6R, 8S, 13S, 14S) ECD spectra of 6 (d), Experimental and calculated (for 2S, 5R, 6R, 13S, 14S, 15S) ECD spectra of 7 (e).
Figure 5X-ray single-crystallography structures of 1 and 2. The ellipsoids of non-hydrogen atoms are shown at 30% probability levels for crystal structures.
Figure 6LPS-induced NO production (a), and viability (b) of RAW 264.7 macrophages by 1–7 treatment. The values represent the mean ± SEM of three independent experiments. *, p < 0.05; **, p < 0.01; ***, p < 0.001 vs. control.